Skip to content

Veronica O’keane

4 papers in the library · 183 citations · publishing 2019-2021

Papers

Sort Most recent Most cited

Psychedelic Therapy's Transdiagnostic Effects: A Research Domain Criteria (RDoC) Perspective

Frontiers in Psychiatry December 17, 2021 John R. Kelly, Claire M. Gillan, Jack Prenderville et al. 66 citations

Accumulating clinical evidence shows that psychedelic therapy, by synergistically combining psychopharmacology and psychological support, offers a promising transdiagnostic treatment strategy for a range of disorders with restricted and/or maladaptive habitual patterns of emotion, cognition and behavior, notably, depression (MDD), treatment resistant depression (TRD) and addiction disorders,...

Psychedelic perceptions: mental health service user attitudes to psilocybin therapy

Irish Journal of Medical Science (1971 -) June 15, 2021 Kate Corrigan, Maeve Haran, Conor Mccandliss et al. 79 citations

Abstract Introduction Despite the rapid advance of psychedelic science and possible translation of psychedelic therapy into the psychiatric clinic, very little is known about mental health service user attitudes. Objectives To explore mental health service user attitudes to psychedelics and psilocybin therapy. Methods A questionnaire capturing demographics, diagnoses, previous psychedelic and...

Psychedelic science in post-COVID-19 psychiatry

Irish Journal of Psychological Medicine August 19, 2020 John R. Kelly, Matthew Crockett, Laith Alexander et al. 16 citations

The medium- to long-term consequences of COVID-19 are not yet known, though an increase in mental health problems are predicted. Multidisciplinary strategies across socio-economic and psychological levels may be needed to mitigate the mental health burden of COVID-19. Preliminary evidence from the rapidly progressing field of psychedelic science shows that psilocybin therapy offers a promising...

The psychedelic renaissance: the next trip for psychiatry?

Irish Journal of Psychological Medicine September 23, 2019 John R. Kelly, Annie Baker, Mona Babiker et al. 22 citations

The psychedelic research renaissance is gaining traction. Preliminary clinical studies of the hallucinogenic fungi, psilocybin, with psychological support, have indicated improvements in mood, anxiety and quality of life. A seminal, open-label study demonstrated marked reductions in depression symptoms in participants with treatment-resistant depression (TRD). The associated neurobiological...